Source / episode info

• **Episode:**341
• **Title:**Divine Intervention Episode 341 – Lupus and The USMLEs.
• **Published:**2021-09-22
• Source:Episode page

One-liner

This episode provides a comprehensive review of Systemic Lupus Erythematosus (SLE), emphasizing its multi-system involvement, Type III hypersensitivity pathophysiology, classic clinical manifestations (e.g., nephritis, serositis, rash), diagnostic workup, and differential diagnoses from conditions like rheumatoid arthritis and drug-induced lupus.

High-yield summary

• Pathophysiology: SLE is primarily driven by Type III hypersensitivity reactions resulting from the deposition of immune complexes (e.g., anti-dsDNA/anti-histone) in various tissues, causing inflammation and damage.
• Diagnosis & Monitoring: The ANA test is highly sensitive for lupus but non-specific; confirmation requires high specificity antibodies like Anti-double-stranded DNA (anti-dsDNA) or Anti-Smith (anti-Sm). Anti-dsDNA levels often correlate with disease activity, especially nephritis.
• Nephritis Management: Suspected lupus nephritis always requires a renal biopsy before initiating definitive treatment due to the multiple types of glomerulonephritis.
• Serositis/Dermatology: Serosal surfaces (pleura, pericardium) are common targets; inflammation often responds well to NSAIDs. The malar rash classically worsens with sun exposure.
• Differential Diagnosis: SLE arthritis is typically non-erosive and symmetric, contrasting sharply with the erosive and asymmetric joint damage seen in Rheumatoid Arthritis (RA).
• Drug-Induced Lupus (DIL): Characterized by anti-histone antibodies, lacks anti-dsDNA/anti-Sm antibodies, and generally spares severe organ involvement (e.g., CNS, kidneys) compared to SLE. Treatment is stopping the offending agent.

Learning objectives

• Differentiate the pathophysiology of SLE manifestations (Type III hypersensitivity vs. Type II).
• Recognize the classic clinical presentations and associated autoantibodies for various lupus syndromes (e.g., nephritis, serositis, vasculitis).
• Establish the necessary diagnostic workup for suspected lupus nephritis, including biopsy requirements.
• Distinguish between primary SLE and drug-induced lupus based on antibody profile and severity of organ damage.
• Identify key differential diagnoses for malar rash and arthritis (e.g., sarcoidosis, RA).